{"id":"https://openalex.org/W2188295528","doi":null,"title":"Dopamine agonists for the treatment of cocaine dependence (Review)","display_name":"Dopamine agonists for the treatment of cocaine dependence (Review)","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2188295528","mag":"2188295528"},"language":"en","primary_location":{"id":"mag:2188295528","doi":null,"is_oa":false,"landing_page_url":"https://www.iss.it/binary/drog4/cont/Dopamine_agonists_Cochrane_2011_update.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072806973","display_name":"Laura Amato","orcid":"https://orcid.org/0000-0003-0282-0881","observed_orcids":["https://orcid.org/0000-0003-0282-0881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Amato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0282-0881","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050689894","display_name":"Silvia Minozzi","orcid":"https://orcid.org/0000-0003-0471-8581","observed_orcids":["https://orcid.org/0000-0003-0471-8581"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Minozzi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0471-8581","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Pani Pp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pani Pp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091764313","display_name":"Renata Solimini","orcid":"https://orcid.org/0000-0001-8737-4504","observed_orcids":["https://orcid.org/0000-0001-8737-4504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renata Solimini","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8737-4504","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002794846","display_name":"Simona Vecchi","orcid":"https://orcid.org/0000-0002-3893-8403","observed_orcids":["https://orcid.org/0000-0002-3893-8403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simona Vecchi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3893-8403","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111920610","display_name":"Piergiorgio Zuccaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Zuccaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"L Davoli","orcid":"https://orcid.org/0000-0001-9374-6271","observed_orcids":["https://orcid.org/0000-0001-9374-6271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Davoli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9374-6271","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.2395000010728836,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":1.0},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4582613408565521},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3954234719276428},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37759560346603394},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.21009430289268494}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188295528","doi":null,"is_oa":false,"landing_page_url":"https://www.iss.it/binary/drog4/cont/Dopamine_agonists_Cochrane_2011_update.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2607685219","https://openalex.org/W2172120323","https://openalex.org/W1978579582","https://openalex.org/W2016164498","https://openalex.org/W2267731026","https://openalex.org/W2006037998","https://openalex.org/W2028780928","https://openalex.org/W32010167","https://openalex.org/W2043692632","https://openalex.org/W3009022164"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}